Alabama Womb to Heart Solution Testing Community Health Worker Support to Lower Blood Pressure After Pregnancy-Related Hypertension
Led by University of Alabama at Birmingham · Updated on 2026-10-28
174
Participants Needed
1
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
This research evaluates whether support from a community health worker CHW can help lower blood pressure in postpartum patients who had high blood pressure during or after pregnancy, such as preeclampsia, gestational hypertension, eclampsia, or HELLP syndrome. The trial focuses on reducing future heart disease risk by improving blood pressure control during a critical period after delivery. It is a randomized controlled trial conducted at the University of Alabama at Birmingham involving 174 postpartum patients with pregnancy-associated hypertension or stage 2 hypertension.
Participants are randomly assigned to either usual care or usual care plus the AW2H CHW program. Both groups receive education on self-measuring blood pressure and a pregnancy-validated home blood pressure monitor. The CHW group also receives coaching and support from a community health worker for six months, including home blood pressure monitoring guidance, medication adherence help, heart-healthy behavior coaching based on the American Heart Associations Lifes Essential 8, scheduling of primary care visits, mother-baby education, and emotional support. CHW contacts occur about twice weekly for the first five weeks, weekly for weeks six to twelve, and monthly for weeks thirteen to twenty-six, either in person or virtually.
Participants are involved in monitoring their blood pressure at home with a study-provided device, observed by research staff either in person or remotely. The main measure is systolic blood pressure six months after enrollment. Secondary outcomes include diastolic blood pressure and whether participants have scheduled a primary care visit. The study also includes interviews and focus groups to explore experiences with the CHW program. Total participation lasts six months, with ongoing support and assessments during this period.
CONDITIONS
Brief Title
Community Health Worker Support to Lower Blood Pressure After a Pregnancy With High Blood Pressure
Research Team
J
Jesse Rattan, PhD, MPH, RN
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Collaborating Sponsor
How This Trial Compares With Other Options
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
Factors
Usual Care + AW2H CHW Program
Usual Postpartum Care + SMBP Education
What it is
A six-month, structured behavioral support program involving community health workers who coach home BP monitoring, reinforce medication adherence, educate on postpartum risks, assist with care navigation, and provide emotional support for mothers after hypertensive pregnancy.
Standardized postpartum care including self-measured BP education, a validated home BP cuff, and written materials addressing hypertensive disorders of pregnancy, cardiovascular risk, and postpartum warning signs.
Role in trial
Investigational arm—tests whether adding CHW support improves BP and postpartum care outcomes beyond usual care.
Active comparator—serves as the benchmark reflecting standard postpartum management for hypertension.
Primary use
Provides intensive postpartum behavioral support focused on blood pressure control, medication adherence, health education, postpartum visit completion, and reducing long-term cardiovascular risks.
Supports self-management of BP through education, provision of validated home BP monitor, and written materials to increase awareness and recognition of postpartum warning signs.
How it is given or performed
CHWs maintain frequent contact—two times per week initially; contacts become weekly and then monthly. CHWs use in-person or virtual visits to provide education, support, scheduling help, and monitor adherence.
Participants receive SMBP education and a pregnancy-validated BP cuff before discharge, with written guidance for self-monitoring and risk awareness.
Evidence status
Early pilot studies in similar populations suggest CHW programs can improve postpartum follow-up and support BP control, but large-scale effectiveness data are still being gathered.
Blood pressure education and validated SMBP devices are guideline-backed and supported by extensive evidence for improving BP awareness and recognition of hypertension risks in postpartum patients.
Important limitations
CHW program effectiveness relies on participant engagement and completion of frequent contacts; potential variation in uptake and real-life adherence may affect outcomes. Full-scale evidence on BP improvement and CVD risk reduction is pending.
Usual care with SMBP and written education may have limited follow-up and lower engagement, particularly in populations with social or logistical barriers. Real-life long-term BP control and care connection depend on patient initiative.
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
Who Can Participate
Age: 16Years - 56Years
FEMALE
Eligibility Criteria
You may qualify if you...
Postpartum patients with pregnancy-associated hypertension or stage 2 hypertension on two occasions around delivery or postpartum
Delivered in the last six weeks at 14 or more weeks gestation, including pregnancy loss
Age between 16 and 56 years
Able to speak and write in English
Delivered at University of Alabama at Birmingham Hospital
You will not qualify if you...
Declines randomization
Does not speak English
Currently incarcerated
Enrolled in other community health worker studies or services
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Treatment
Duration - 6 months
Participants receive usual postpartum care which includes education on self-measuring blood pressure, a home blood pressure monitor, and written materials. Some participants also receive coaching and support from a community health worker for six months, with visits or contacts in person or virtually at varying frequencies.
Contacts about 2 times per week for weeks 1-5, weekly for weeks 6-12, and monthly for weeks 13-26
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Multicenter Study on Maternal and Infant Microbiome and New Screening Targets for Preeclampsia in Pregnant Women in China
Randomized Trial of Dapagliflozin for Lowering Heart Risk After Hypertensive Pregnancy in the Postpartum Period
Study of Safety and Effects of Single Dose CBP-4888 Injection in Hospitalized Pregnant Women with Preterm Preeclampsia
and Follow-Up of Their Children up to 24 Months
Observational Study Evaluating Blood Biomarkers and Retinal Imaging to Predict Pregnancy Complications in First-Time Pregnant Women
Using Angiogenic Factors to Guide Pregnancy Management in Women with Gestational Hypertension
A Randomized Study Comparing Timing of Delivery at 37 vs 39 Weeks
Antidepressant Therapy to Improve Blood Vessel Function After Preeclampsia in Women
How Assisted Reproductive Technologies Influence Pregnancy and Newborn Outcomes
A Multicenter Study Comparing Singleton and Multiple Pregnancies
Study of Urinary Tract Infections and Their Link to Preeclampsia in Pregnant Women Aged 18 to 35 in Pakistan
Randomized Trial of Atorvastatin to Reduce Cardiovascular Risk After Hypertensive Pregnancy Disorders
Study of Immune Cell and Placental Cell Interaction in Pregnancy Disorders Including Preeclampsia and Diabetes
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Life's Essential 8: Updating and Enhancing the American Heart Association's Construct of Cardiovascular Health: A Presidential Advisory From the American Heart Association.
Donald M Lloyd-Jones, Norrina B Allen, Cheryl A M Anderson...
Opportunities in the Postpartum Period to Reduce Cardiovascular Disease Risk After Adverse Pregnancy Outcomes: A Scientific Statement From the American Heart Association.
Jennifer Lewey, Theresa M Beckie, Haywood L Brown...